REQUEST A DEMO
Total
USD $0.00
Search more companies

Sandoz SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Sandoz SRL Profile Updated: February 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The company was founded in 1996, under the name PharmaTech, having its headquarters in Targu Mures. Lek PharmaTech was the first Romanian producer of pediatric suspensions. Since January 2001, the international pharmaceutical company Lek Pharmaceuticals d.d., based in Ljubljana, Slovenia acquired Pharmatech and formed Lek PharmaTech. In 2002 Lek d.d merger with Novartis, Lek PharmaTech company became part of Novartis group and in the same year penicillines factory was upgraded to GMP standards. In 2003 in the framework of Novartis Generics, several national brands formed one strong brand - Sandoz. In 2006, with the purpose to consolidate local integrations on Romanian market of PharmaTech, Lek, Biochemie, Hexal was decided to bring back Sandoz in Romania. On February 28, 2006 Lek Pharmatech S.R.L. changed its name to Sandoz SRL

Headquarters
Strada Livezeni Nr. 7A
TARGU MURES; Mures;

Contact Details: Purchase the Sandoz SRL report to view the information.

Basic Information
Total Employees:
Purchase the Sandoz SRL report to view the information.
Outstanding Shares:
Purchase the Sandoz SRL report to view the information.
Registered Capital:
Purchase the Sandoz SRL report to view the information.
Financial Auditors:
Purchase the Sandoz SRL report to view the information.
Incorporation Date:
June 26, 1995
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sandoz SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
24.12%
Total operating revenue
23.35%
Operating profit (EBIT)
21.9%
EBITDA
22.08%
Net Profit (Loss) for the Period
13.91%
Total assets
2.34%
Total equity
7.03%
Operating Profit Margin (ROS)
-0.09%
Net Profit Margin
-0.32%
Return on Equity (ROE)
0.4%
Debt to Equity Ratio
-2.77%
Quick Ratio
-0.54%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?